CASRAI News · Editor

Gabriel Nieves Castro edits CASRAI News and serves on the board of CASRAI, a standards organisation for research administration and scholarly communication. He reviews the news published here on research funding, regulation, research security, research integrity, scholarly publishing and AI in science. He is the founder and chief executive of LAC Healthcare Solutions, a wholesale medical-supply company he has led since its founding in 2014, founded Altos Group, and chairs the board of The Health Initiative, a healthcare and food-security 501(c)(3) serving Puerto Rico and the continental United States.
What he does here
He reviews the news CASRAI publishes and is the person accountable for it. Stories are reported from primary sources (the rule, notice, filing, paper or statement itself) and at least two independent outlets, and each one says what the development means for researchers, universities and research offices. Corrections go to the editorial policy process; the wider editorial body is listed on the editorial board page.
Areas covered
- Research administration
- Research funding and science policy
- Research regulation and compliance
- Standards development
- Healthcare procurement
- Medical device regulatory compliance
Recent news
- New UN Landmark Report: Exposure to Hormone-Disrupting Chemicals Starts Before Birth18 Nov 2026
- Former NIH neuroscientist Eliezer Masliah reaches 32 retractions, 15 of them in 202618 Nov 2026
- U.S. Expands AI Chip Export Controls Amid Southeast Asian Data Center Scrutiny18 Nov 2026
- Nvidia chips reach China via Southeast Asian data centres18 Nov 2026
- South Korea Tightens Exam Security After AI Cheating Scandal18 Nov 2026
- NIH Rescinds Autism Research Data Sharing Notice NOT-MH-09-00518 Nov 2026
- Fei-Fei Li: Public Sector and Universities “Priced Out” of AI Research18 Nov 2026
- Alphabet’s Isomorphic Labs raises $5B to accelerate drug discovery with AI18 Nov 2026
- US AI Chip Export Rule: 5 Countries, 90 Days18 Nov 2026
- Former NIH neuroscientist reaches 30 retractions18 Nov 2026
- WHO to add two Bundibugyo vaccine candidates to Tumaini Ebola trial as DR Congo cases pass 11,00018 Nov 2026
- FDA Launches Global Reliance Disclosure Program to Share Approval Packages With Foreign Regulators18 Nov 2026
- UNEP and WHO publish first global update on endocrine-disrupting chemicals since 201218 Nov 2026
- Singapore Assesses Impact of New US Export Controls on Advanced Semiconductors18 Nov 2026
- US Supreme Court Preserves Academic Grant Protections18 Nov 2026
- Nvidia CEO Resignation Amid Export Control Investigation18 Nov 2026
- WHO Reports Chikungunya Virus Outbreak in Switzerland17 Nov 2026
- NSF Walks Back Contested Grant Rule Changes17 Nov 2026
- U.S. Expands AI Chip Export Curbs to Southeast Asia to Close Loopholes17 Nov 2026
- Springer Nature raises 2026 outlook as research articles grow 12% and transformative deals reach 10517 Nov 2026







